Heat Shock Proteins and Their Use as Anticancer Vaccines

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Cancer Research

• Publication date

  2004-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-04-1194PMID 15623587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A listing of human tumor antigens recognized by T cells: March 2004 update

  2005cited by this paper
• HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation.

  2004cited by this paper
• A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8 T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein

  2004cited by this paper
• E1696: Final analysis of the clinical and immunological results of a multicenter ECOG phase II trial of multi-epitope peptide vaccination for stage IV melanoma with MART-1 (27-35), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) (MGT) +/- IFN{alpha}2b and GM-CSF

  2004cited by this paper
• Enhanced Efficacy of Tumor Cell Vaccines Transfected with Secretable hsp70

  2004cited by this paper
• Phase II study of HSPPC-96 in combination with GM-CSF and IFN-α in stage IV malignant melanoma.

  2004cited by this paper
• The Cell Surface-Localized Heat Shock Protein 70 Epitope TKD Induces Migration and Cytolytic Activity Selectively in Human NK Cells 1

  2004cited by this paper
• A Role for Toll-Like Receptor 4 in Dendritic Cell Activation and Cytolytic CD8+ T Cell Differentiation in Response to a Recombinant Heat Shock Fusion Protein1

  2004cited by this paper
• Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.

  2003cited by this paper
• Vaccination with heat shock protein–peptide complexes: from basic science to clinical applications

  2003cited by this paper
• Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen1

  2003cited by this paper
• Human Tumor-Derived Heat Shock Protein 96 Mediates In Vitro Activation and In Vivo Expansion of Melanoma- and Colon Carcinoma-Specific T Cells1

  2003cited by this paper
• Re-evaluating the role of heat-shock protein–peptide interactions in tumour immunity

  2003cited by this paper
• Novel CD8+ T Cell Antagonists Based on β2-Microglobulin*

  2002cited by this paper
• The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 Pathway*

  2002cited by this paper
• Heat-shock proteins as activators of the innate immune system.

  2002cited by this paper
• Heat-shock proteins as activators of the innate immune system.

  2002cited by this paper
• Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.

  2002cited by this paper
• Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells1

  2002cited by this paper
• Novel Signal Transduction Pathway Utilized by Extracellular HSP70

  2002cited by this paper
• Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

  2002cited by this paper
• Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

  2002cited by this paper
• Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.

  2002cited by this paper
• Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

  2001cited by this paper
• High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.

  2001cited by this paper
• CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

  2001cited by this paper
• Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.

  2001cited by this paper
• Immunization of cancer patients with autologous cancer‐derived heat shock protein gp96 preparations: A pilot study

  2000cited by this paper
• Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

  2000cited by this paper
• Cutting Edge: Heat Shock Protein gp96 Induces Maturation and Migration of CD11c+ Cells In Vivo1

  2000cited by this paper
• The heat shock protein gp96 induces maturation of dendritic cells and down‐regulation of its receptor

  2000cited by this paper
• The Hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s

  2000cited by this paper
• Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.

  1999cited by this paper
• Antitumor immunity at work in a melanoma patient.

  1999cited by this paper
• Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

  1997cited by this paper
• Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

  1996influential reference
• Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

  1996cited by this paper
• A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

  1995cited by this paper

• Disruption of CD91 association with AXL and Fgr abrogates HSP-mediated signaling and cancer immunosurveillance

  2025cites this paper
• Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases

  2023cites this paper
• Methods for improving the immunogenicity and efficacy of cancer vaccines

  2018cites this paper
• Heat Shock Protein as an Adjuvant in Veterinary Vaccines

  2017cites this paper
• Complexes of trophoblastic peptides and heat shock protein 70 as a novel contraceptive vaccine in a mouse model.

  2016cites this paper
• Grp94 in complexes with IgG is a soluble diagnostic marker of gastrointestinal tumors and displays immune-stimulating activity on peripheral blood immune cells

  2016cites this paper
• Induction of Immunogenic Tumor Cell Death by Attenuated Oncolytic Measles Virus

  2015cites this paper
• Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancer

  2014cites this paper
• lymphomas Heat shock protein 70 regulates Tcl1 expression in leukemia and

  2013cites this paper
• Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.

  2013cites this paper
• The potential of clusterin to act as an immune modulator

  2013cites this paper
• LYMPHOID NEOPLASIA Heat shock protein 70 regulates Tcl 1 expression in leukemia and lymphomas

  2013cites this paper
• Hsp70, a messenger from hyperthermia for the immune system.

  2012cites this paper
• Heat Shock Proteins in the Cancer Immunity: Comprehensive Review on Potential Chemotherapeutic Interventions

  2012cites this paper
• Cancer and Innate Immune System Interactions: Translational Potentials for Cancer Immunotherapy

  2012cites this paper
• Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis

  2012cites this paper
• Vaccine-Based Immunotherapy and Targeting the Tumor Microenvironment in Renal Cell Carcinoma

  2012cites this paper
• Heat shock protein-peptide complex-96 (Vitespen) for the treatment of cancer

  2011influential citation
• Hsp70, a messenger from hyperthermia for the immune system

  2011cites this paper
• Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors

  2011influential citation
• Cancer Vaccine by Fusions of Dendritic and Cancer Cells

  2010cites this paper
• Molecular chaperones and protein‐folding catalysts as intercellular signaling regulators in immunity and inflammation

  2010cites this paper
• 小细胞肺癌的的分子发病机制

  2010cites this paper
• Heat shock proteins in glioblastomas.

  2010cites this paper
• Induction of tumor-specific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice.

  2010cites this paper
• Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70

  2010cites this paper
• The molecular pathogenesis of small cell lung cancer

  2010cites this paper
• Proteomics: a strategy to understand the novel targets in protein misfolding and cancer therapy

  2010cites this paper
• Heat Shock Protein (HSP)-Based Immunotherapies

  2010cites this paper
• Peptide-based anticancer vaccines: recent advances and future perspectives.

  2009cites this paper
• Polymorphisms in heat shock protein receptors

  2009cites this paper
• Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi

  2009cites this paper
• Silencing of GRP94 expression promotes apoptosis in pancreatic cancer cells.

  2009cites this paper
• Extracellular Hsp70 stimulates multiple signaling pathways in A431 carcinoma cells

  2009cites this paper
• Purification of the 90 kDa heat shock protein (hsp90) and simultaneous purification of hsp70/hsc70, hsp90 and hsp96 from mammalian tissues and cells using thiophilic interaction chromatography.

  2009cites this paper
• Proteomic profiling of heat shock proteins: An emerging molecular approach with direct pathophysiological and clinical implications

  2009cites this paper
• Differential expression of heat shock protein 105 in melanoma and melanocytic naevi

  2008cites this paper
• Cancer vaccines: accomplishments and challenges.

  2008cites this paper
• Vaccine therapy for renal cancer

  2008cites this paper
• Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens

  2008cites this paper
• Pathogen-associated molecular pattern in cancer immunotherapy.

  2008cites this paper
• Heat-shock proteins as powerful weapons in vaccine development

  2008cites this paper
• Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma.

  2008cites this paper
• Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines

  2008cites this paper
• Heat-shock protein–peptide complex-96 for the treatment of cancer

  2007cites this paper
• Review Immune based therapies in cancer

  2007cites this paper
• Heat shock protein-receptor-based pharmacogenomics: the search for new cancer antigens.

  2007cites this paper
• Hsp-based tumor vaccines: state-of-the-art and future directions.

  2007cites this paper
• Immune based therapies in cancer.

  2007cites this paper
• The heterologous overexpression of hsp23, a small heat-shock protein gene from Trichoderma virens, confers thermotolerance to T. harzianum

  2007cites this paper
• Synergistic Induction of Antigen-Specific

  2007cites this paper
• Extracellular Functions for an Intracellular Protein: GRP94/GP96 Interactions with the Mammalian Immune System

  2007cites this paper
• Generation of Tumor-Specific Immunity Using HER2/NEU Positive Tumor Derived Chaperone-Rich Cell Lysate (CRCL)

  2007cites this paper
• Anti-tumor effect of heat shock protein 70-Peptide complexes on A-549 cells

  2007cites this paper
• Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells

  2007cites this paper
• Glucose regulated proteins in cancer progression, Drug resistance and immunotherapy

  2006cites this paper
• Immunization with heat shock protein 105-pulsed dendritic cells leads to tumor rejection in mice.

  2006cites this paper
• Heat shock protein-based cancer vaccines.

  2006cites this paper
• Molecular chaperones and cancer immunotherapy.

  2006cites this paper
• Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells1

  2006cites this paper
• A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

  2006cites this paper
• Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology

  2006cites this paper
• Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors

  2006cites this paper
• Vaccination: role in metastatic melanoma

  2006cites this paper
• Heat shock proteins gp96 as immunogens in cancer patients

  2006cites this paper
• Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell–Mediated Patient-Specific Immunotherapy

  2006cites this paper
• Cell-Tumor Fusion Cells DendriticProtein 70 Peptide Complexes from Enhanced Immunogenicity of Heat Shock

  2006cites this paper
• Enhanced Immunogenicity of Heat Shock

  2006cites this paper
• Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?

  2005cites this paper
• HSP90 and the chaperoning of cancer

  2005cites this paper
• Current ideas about applications of heat shock proteins in vaccine design and immunotherapy

  2005cites this paper
• Development of antibody-targeted vaccines.

  2005cites this paper
• Silencing of GRP 94 expression promotes apoptosis in pancreatic cancer cells

  year unknowncites this paper